Now live: Pro — the full 13F research suite for serious investorsSee pricing →
AIGH Capital Management LLC

Q1 2026 · 13F-HR

AIGH Capital Management LLCholdings as filed

Filed 2026-04-30 · accession 0001214659-26-005295

$733.2M
Reported value
43
Positions
2026-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
464287655IWMISHARES TR$148.8M20.3%600,000PUTSOLE
80004C200SNDKSANDISK CORP$127.1M17.3%200,000CommonSOLE
98980L101ZNGAZOOM COMMUNICATIONS INC$56.3M7.67%700,000CALLSOLE
81369Y803XLKSELECT SECTOR SPDR TR$39.9M5.44%300,000PUTSOLE
88675P103TYGOTIGO ENERGY INC$27.4M3.73%7,280,312CommonSOLE
82706C108SIMOSILICON MOTION TECHNOLOGY CO$22.5M3.06%200,000CommonSOLE
989207105ZBRAZEBRA TECHNOLOGIES CORPORATI$20.9M2.85%100,000CommonSOLE
65487K100LASRNLIGHT INC$19.4M2.64%340,000CommonSOLE
921659108VNDAVANDA PHARMACEUTICALS INC$19.0M2.59%2,750,000CommonSOLE
71535D106PSNLPERSONALIS INC$18.5M2.52%2,900,000CommonSOLE
368736104GNRCGENERAC HLDGS INC$17.6M2.40%90,000CommonSOLE
501976104KYTXKYVERNA THERAPEUTICS INC$17.3M2.35%2,000,000CommonSOLE
14843C105CSTLCASTLE BIOSCIENCES INC$14.5M1.98%590,601CommonSOLE
25400W102APPSDIGITAL TURBINE INC$14.1M1.92%4,895,772CommonSOLE
758750103RRXREGAL REXNORD CORPORATION$14.0M1.92%75,000CommonSOLE
00289Y206ABEOABEONA THERAPEUTICS INC$13.9M1.89%3,100,000CommonSOLE
517125100LRMRLARIMAR THERAPEUTICS INC$13.5M1.84%3,000,000CommonSOLE
31447P100FENCFENNEC PHARMACEUTICALS INC$12.2M1.66%1,981,501CommonSOLE
29664W105ESPRESPERION THERAPEUTICS INC NE$12.1M1.64%4,400,000CommonSOLE
488445206ZVRAZEVRA THERAPEUTICS INC$11.2M1.53%1,200,000CommonSOLE
09075X207BDSXBIODESIX INC$11.0M1.50%758,328CommonSOLE
45817G201IDNINTELLICHECK MOBILISA INC$10.6M1.45%1,517,249CommonSOLE
92337C203VSTMVERASTEM INC$10.6M1.45%2,000,000CommonSOLE
74365U107TARAPROTARA THERAPEUTICS INC$8.5M1.15%1,622,733CommonSOLE
92921W300VUZIVUZIX CORP$7.6M1.04%3,295,754CommonSOLE
M8001Q126PYPDPOLYPID LTD$7.0M0.95%1,593,587CommonSOLE
03837C106APYXAPYX MEDICAL CORPORATION$4.1M0.56%1,104,970CommonSOLE
22407B108COYACOYA THERAPEUTICS INC$3.8M0.52%975,404CommonSOLE
05479K106ELUTELUTIA INC$3.8M0.51%3,595,250CommonSOLE
75989R107RNXTRENOVORX INC$3.7M0.50%3,706,197CommonSOLE
00444T209TLPHTALPHERA INC$3.5M0.47%4,661,502CommonSOLE
29272C301WATTENERGOUS CORP$3.4M0.46%215,000CommonSOLE
451622203IPWRIDEAL PWR INC$3.3M0.46%1,181,696CommonSOLE
64134X201NRXSNEURAXIS INC$3.0M0.40%400,000CommonSOLE
05587G203BKTIBK TECHNOLOGIES CORPORATION$2.4M0.33%32,615CommonSOLE
53630X203LPCNLIPOCINE INC NEW$1.6M0.22%200,000CommonSOLE
45170X205INVEIDENTIV INC$1.5M0.21%409,186CommonSOLE
532257805LPTHLIGHTPATH TECHNOLOGIES INC$1.0M0.14%100,000CommonSOLE
M8211G108RGNTREGENTIS BIOMATERIALS LTD$916,5000.12%300,000CommonSOLE
03836J201APREAPREA THERAPEUTICS INC$774,7570.11%1,015,541CommonSOLE
09077D209BFRIBIOFRONTERA INC$740,4050.10%915,210CommonSOLE
74907L409QNRXQUOIN PHARMACEUTICALS LTD$336,6000.05%51,000CommonSOLE
83193D203SMTKSMARTKEM INC$203,7140.03%895,449CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.